Fentora Approved for Cancer Pain
(HealthDay)


HealthDay - TUESDAY, Sept. 26 (HealthDay News) -- Cephalon Inc.'s Fentora (fentanyl buccal tablet) has been approved by the U.S. Food and Drug Administration to treat so-called "breakthrough" pain in those who have cancer. This type of pain -- characterized by its rapid onset, intensity and short duration -- affects about 800,000 cancer patients, the American Cancer Society says.